This is the authors' abstract. We don't add key points for this paper.
The efficacy of albendazole was investigated in 112 patients with symptomatic gnathostomiasis; 49 received 400 mg twice daily, 51 received 400 mg once daily, and 12 patients received placebo, all for 21 d. Subsequent follow-up was for 6 months. Cure (no further swelling) was seen in 93.9% and 94.1% of the treatment groups but in none of the placebo group. Additionally, reductions in eosinophil counts and in immunoglobulin G antibody were observed after treatment. Side effects were minimal. Albendazole may be an effective compound for the treatment of gnathostomiasis.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Kraivichian et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: